Free Trial

Chemed Co. (NYSE:CHE) Director Sells $238,988.00 in Stock

Chemed logo with Medical background

Chemed Co. (NYSE:CHE - Get Free Report) Director George J. Walsh III sold 400 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now owns 3,046 shares of the company's stock, valued at $1,819,893.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Chemed Stock Down 0.2 %

Shares of Chemed stock traded down $1.02 on Friday, reaching $599.04. The company's stock had a trading volume of 59,216 shares, compared to its average volume of 83,993. The company has a market capitalization of $9.07 billion, a P/E ratio of 32.24, a PEG ratio of 2.40 and a beta of 0.44. Chemed Co. has a 52-week low of $497.36 and a 52-week high of $654.62. The stock has a 50-day moving average price of $574.54 and a 200-day moving average price of $576.44.

Chemed (NYSE:CHE - Get Free Report) last announced its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts' consensus estimates of $5.59 by ($0.12). The firm had revenue of $595.88 million for the quarter, compared to analyst estimates of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. Chemed's revenue was up 7.6% compared to the same quarter last year. During the same period in the previous year, the company earned $4.71 EPS. Sell-side analysts forecast that Chemed Co. will post 21.77 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were given a $0.50 dividend. The ex-dividend date of this dividend was Monday, August 12th. This is a positive change from Chemed's previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. Chemed's dividend payout ratio is 10.76%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Corient Private Wealth LLC grew its holdings in shares of Chemed by 7.9% during the 4th quarter. Corient Private Wealth LLC now owns 2,741 shares of the company's stock worth $1,603,000 after purchasing an additional 200 shares during the period. Franklin Resources Inc. boosted its position in shares of Chemed by 45.4% during the fourth quarter. Franklin Resources Inc. now owns 9,861 shares of the company's stock worth $5,766,000 after buying an additional 3,077 shares during the period. Advisory Services Network LLC grew its stake in shares of Chemed by 3.3% in the fourth quarter. Advisory Services Network LLC now owns 1,013 shares of the company's stock valued at $593,000 after buying an additional 32 shares in the last quarter. Intech Investment Management LLC raised its holdings in shares of Chemed by 82.6% in the 4th quarter. Intech Investment Management LLC now owns 1,059 shares of the company's stock valued at $619,000 after buying an additional 479 shares during the period. Finally, Parallel Advisors LLC lifted its stake in Chemed by 13.9% during the 4th quarter. Parallel Advisors LLC now owns 901 shares of the company's stock worth $527,000 after acquiring an additional 110 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

About Chemed

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Should you invest $1,000 in Chemed right now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Inflation-Busting Dividends: 3 Stocks Raising Payouts 4X Faster
Why Congress Is Betting Big on Chubb: The Underrated Insurance Stock
AST SpaceMobile Takes Major Leap in Global Connectivity with Satellite Launch

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines